Breaking

MP Materials, US Department of Defense Strike Saudi Rare Earths Refinery Deal
Crypto Market Update: Bitcoin Price Logs Weakest Month Since 2022
Tech Weekly: NVIDIA Earnings Impress, Bezos Launches AI Startup
U.S. added 119,000 jobs in September, but there are signs of a weakening labor market
Bargain hunters drive Walmart sales and outlook higher
Intention to Explore Dual Listings
First Nation-Owned Minago Project Pushes Manitoba into Critical Minerals Spotlight
WPIC: Platinum Market Set for 2026 Stability After Years of Deep Deficits

Facebook
Twitter
Google Plus
Instagram
Pinterest
Vimeo

Investing
Stock
Latest News
Editor’s Pick
Economy
Search for:

Investing

First patient dosed in Phase IIb imaging for Brain Mets

By April 28, 2025

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Crypto Market Update: Bitcoin Price Logs Weakest Month Since 2022

November 21, 2025

MP Materials, US Department of Defense Strike Saudi Rare Earths Refinery Deal

November 21, 2025

Tech Weekly: NVIDIA Earnings Impress, Bezos Launches AI Startup

November 21, 2025

Enter Your Information Below To Receive Latest News, And Articles.
Your name

Your email
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest Posts
Categories
- Economy (1,028)
- Editor's Pick (633)
- Investing (5,109)
- Latest News (3,536)
- Stock (1,161)
About Rightinvestingway

Disclaimer: Rightinvestingway.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 Rightinvestingway.com

Top

Type above and press Enter to search. Press Esc to cancel.